About this trial

The purpose of this prospective, observational study is to evaluate the clinical and functional outcomes of ultrasound-guided Pericapsular Nerve Group (PENG) block in patients suffering from chronic shoulder pain. Chronic shoulder pain is a highly prevalent musculoskeletal problem that significantly restricts daily activities and diminishes the patient's quality of life. While conservative treatments and various interventional injections are widely used, long-term efficacy can be limited, and systemic side effects may occur. The shoulder PENG block is a novel regional analgesia technique that specifically targets the articular (sensory) branches of the nerves innervating the shoulder joint capsule without affecting the motor branches. In this single-center study, a total of 45 eligible adult patients with chronic shoulder pain who did not respond to conservative medical treatments will receive an ultrasound-guided PENG block as part of their routine clinical care. The procedure will be performed under sterile conditions using a combination of local anesthetic (lidocaine) and dexamethasone. Patient pain levels will be assessed using the Numerical Rating Scale (NRS), shoulder disability and functional status will be measured using the Shoulder Pain and Disability Index (SPADI), and overall patient satisfaction will be evaluated using the Global Perceived Effect (GPE) score. All parameters will be documented at baseline (before the procedure) and at follow-up visits on the 1st week, 4th week (1 month), and 3rd month post-procedure. The investigators aim to determine the efficacy, duration of effect, and safety profile of this intervention.

Eligibility criteria

Qualifiers

Age 18 years or older.

Patients presenting with chronic shoulder pain lasting longer than 3 months.

Initial pain intensity score greater than 4 on the Numerical Rating Scale (NRS > 4).

Patients who have not responded to conservative or medical treatments.

Disqualifiers

Patients currently using anticoagulants or diagnosed with coagulation disorders (bleeding diathesis).

Patients with psychomotor or cognitive disorders that prevent cooperative evaluation.

Presence of active bacterial infection, open wounds, or infectious discharge at the planned needle injection site.

History of shoulder surgery at the intervention site within the last 6 months.

Trial design

Treatments tested in this trial

  • Lidocaine and Dexamethasone for PENG Block

Treatment groups

45 Participants
are divided into 1 treatment group

Locations

1
Ankara Bilkent City Hospital06810, Ankaraçankaya, Turkey (Türkiye)

Sponsors and collaborators

Ankara City Hospital Bilkent

Lead sponsor